Antimicrobial resistance of Acinetobacter baumannii to imipenem in Iran: A systematic review and meta-analysis

Open Microbiology Journal

Volumn 10, Issue , 2016, Pages 32-42

  Pourhajibagher, Maryam ^a   Hashemi, Farhad B ^a   Pourakbari, Babak ^a   Aziemzadeh, Masoud ^b   Bahador, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter baumannii; Imipenem; Infection; Iran; Multi drug resistant; Nosocomial

Indexed keywords

IMIPENEM;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; CORRELATION ANALYSIS; DATA EXTRACTION; INFECTION CONTROL; IRAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNTHESIS; SYSTEMATIC REVIEW;

EID: 84971597342     PISSN: None     EISSN: 18742858     Source Type: Journal    
DOI: 10.2174/1874285801610010032     Document Type: Review

References (78)

1. Chittawatanarat K, Jaipakdee W, Chotirosniramit N, Chandacham K, Jirapongcharoenlap T. Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit. Infect Drug Resist 2014; 7: 203-10. [http://dx.doi.org/10.2147/IDR.S67267] [PMID: 25152627]
2. Bayuga S, Zeana C, Sahni J, Della-Latta P, el-Sadr W, Larson E. Prevalence and antimicrobial patterns of Acinetobacter baumannii on hands and nares of hospital personnel and patients: the iceberg phenomenon again. Heart Lung 2002; 31(5): 382-90. [http://dx.doi.org/10.1067/mhl.2002.126103][PMID: 12487017]
3. Gulati S, Kapil A, Das B, Dwivedi SN, Mahapatra AK. Nosocomial infections due to Acinetobacter baumannii in a neurosurgery ICU. Neurol India 2001; 49(2): 134-7. [PMID: 11447431]
4. Rodríguez Guardado A, Maradona JA, Asensi V, et al. Postsurgical meningitis caused by Acinetobacter baumannii: study of 22 cases and review of the literature. Rev Clin Esp 2001; 201(9): 497-500. [http://dx.doi.org/10.1016/S0014-2565(01)70895-8] [PMID: 11692403]
5. Wang KW, Chang WN, Huang CR, et al. Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes. J Clin Neurosci 2005; 12(6): 647-50. [http://dx.doi.org/10.1016/j.jocn.2004.09.017] [PMID: 16023857]
6. Krol V, Hamid NS, Cunha BA. Neurosurgically related nosocomial Acinetobacter baumannii meningitis: report of two cases and literature review. J Hosp Infect 2009; 71(2): 176-80. [http://dx.doi.org/10.1016/j.jhin.2008.09.018] [PMID: 19084290]
7. Tang SS, Apisarnthanarak A, Hsu LY. Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community-and healthcare-associated multidrug-resistant bacteria. Adv Drug Deliv Rev 2014; 78: 3-13. [http://dx.doi.org/doi:101016/jaddr201408003.]
8. Hsueh PR, Teng LJ, Chen CY, et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis 2002; 8(8): 827-32. [http://dx.doi.org/10.3201/eid0805.020014] [PMID: 12141969]
9. Li J, Rayner CR, Nation RL, et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2006; 50(9): 2946-50. [http://dx.doi.org/10.1128/AAC.00103-06] [PMID: 16940086]
10. Olaitan AO, Berrazeg M, Fagade OE, Adelowo OO, Alli JA, Rolain JM. Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase, Nigeria. Int J Infect Dis 2013; 17(6): e469-70. [http://dx.doi.org/10.1016/j.ijid.2012.12.008] [PMID: 23337460]
11. Mezzatesta ML, D’Andrea MM, Migliavacca R, et al. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy. Clin Microbiol Infect 2012; 18(2): 160-6. [http://dx.doi.org/10.1111/j.1469-0691.2011.03527.x] [PMID: 21722261]
12. Yamamoto M, Nagao M, Matsumura Y, et al. Regional dissemination of Acinetobacter species harbouring metallo-β-lactamase genes in Japan. Clin Microbiol Infect 2013; 19(8): 729-36. [http://dx.doi.org/10.1111/1469-0691.12013] [PMID: 23009350]
13. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151(4): 264-269, W64. [http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00135] [PMID: 19622511]
14. Salimizand H, Menbari S, Ramazanzadeh R, Khonsha M, Vahedi MS. DNA fingerprinting and antimicrobial susceptibility pattern of clinical and environmental Acinetobacter baumannii isolates: a multicentre study. J Chemother 2014. [EPUB ahead of print]. [http://dx.doi.org/1973947814Y0000000227] [PMID: 25413132]
15. Salimizand H, Modarresi F, Azizi O, et al. Antimicrobial profile and phenotypic Metallo-β-Lactamase detection of Acinetobacter baumanii isolated from clinical and environmental specimens. Zah J Res Med Sci 2014; 17: 21-4.
16. Alavi-Moghadam M, Miri M, Mokhtari M, et al. Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU). Caspian J Intern Med 2014; 5(3): 186-7. [PMID: 25202450]
17. Ahmadi K, Mardaneh J, Saadat S. Determination antimicrobial resistance profile of Acinetobacter strains isolated from hospitalized patients in different part of Taleghani hospital (Ahvaz, Iran). ISMJ 2014; 17: 620-8.
18. Sharif M, Mirnejad R, Amirmozafari N. Molecular identification of TEM and SHV extended spectrum β-lactamase in clinical isolates of Acinetobacter baumannii from Tehran hospitals. J Gen Microb Immun 2014; 2: 1-9. [http://dx.doi.org/10.5899/2014/jgmi-00020]
19. Nasrolahei M, Zahedi B, Bahador A, et al. Distribution of bla(OXA-23), ISAba, Aminoglycosides resistant genes among burned & ICU patients in Tehran and Sari, Iran. Ann Clin Microbiol Antimicrob 2014; 13: 38-41. [http://dx.doi.org/10.1186/s12941-014-0038-0] [PMID: 25252850]
20. Mohajeri P, Farahani A, Feizabadi MM, et al. The prevalence of ESBL isolates of Acinetobacter baumannii using Pulsed- Field Gel Electrophoresis. Zah J Res Med Sci 2014; 16: 20-3.
21. Abdi-Ali A, Hendiani S, Mohammadi P, Gharavi S. Assessment of biofilm formation and resistance to imipenem and ciprofloxacin among clinical isolates of Acinetobacter baumannii in Tehran. Jundishapur J Microbiol 2014; 7(1): e8606. [http://dx.doi.org/10.5812/jjm.8606] [PMID: 25147652]
22. Fallah F, Noori M, Hashemi A, et al. Prevalence of blaNDM, blaPER, blaVEB, blaIMP, and blaVIM Genes among Acinetobacter baumannii Isolated from two hospitals of Tehran, Iran. Scientifica 2014. Volume 2014. Available from: http://www.hindawi.com/journals/scientifica/2014/245162/ [http://dx.doi.org/10.1155/2014/245162]
23. Soltani R, Ehsanpoor M, Khorvash F, Shokri D. Antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing bacteria causing nosocomial urinary tract infections in an Iranian referral teaching hospital. J Res Pharm Pract 2014; 3(1): 6-11. [http://dx.doi.org/10.4103/2279-042X.132703] [PMID: 24991629]
24. Mohajeri P, Farahani A, Feizabadi MM, Ketabi H, Abiri R, Najafi F. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iran J Microbiol 2013; 5(3): 195-202. [PMID: 24475323]
25. Haeili M, Ghodousi A, Nomanpour B, Omrani M, Feizabadi MM. Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011. J Infect Dev Ctries 2013; 7(4): 312-7. [http://dx.doi.org/10.3855/jidc.2604] [PMID: 23592640]
26. Goudarzi H, Douraghi M, Ghalavand Z, et al. Assessment of antibiotic resistance pattern in Acinetobacter baumannii carrying blaOXA type genes isolated from hospitalized patients. Novel Biomed 2013; 1: 54-61.
27. Azimi L, Lari AR, Talebi M, Namvar AE, Jabbari M. Comparison between phenotypic and PCR for detection of OXA-23 type and metallobeta- lactamases producer Acinetobacter spp. GMS Hyg Infect Control 2013; 8(2): Doc16. [PMID: 24327942]
28. Alaei N, Bahador A, Harzandi N. Molecular epidemiology & antimicrobial resistance of Acinetobacter baumannii isolated from Namazi hospital, in Shiraz by modified AFLP analysis. J Microbial World 2013; 6: 91-104.
29. Safari M, Saidijam M, Bahador A, Jafari R, Alikhani MY. High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. J Res Health Sci 2013; 13(2): 162-7. [PMID: 24077474]
30. Sadeh M, Goudarzi H, Eslami G, et al. Evaluation of beta-lactamase gene (blaTEM, blaCTX) resistant to drug and glutaraldehid in Acinetobacter baumannii isolates. J Shahid Beheshti Univ 2013; 37: 232-8.
31. Azimi L, Rastegar Lari A, Alaghehbandan R, Alinejad F, Mohammadpoor M, Rahbar M. KPC-producer gram negative bacteria among burned infants in Motahari Hospital, Tehran: first report from Iran. Ann Burns Fire Disasters 2012; 25(2): 74-7. [PMID: 23233824]
32. Jafari S, Najafipour S, Kargar M, et al. Phenotypical evaluation of multi-drug resistant Acinetobacter baumannii. J Fasa Univer Med Sci 2012; 2: 254-8.
33. Owlia P, Azimi L, Gholami A, Asghari B, Lari AR. ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients. Infez Med 2012; 20(3): 182-7. [PMID: 22992558]
34. Peymani A, Nahaei MR, Sohrabi N, et al. Clonal isolates of Acinetobacter baumannii with multiple drug resistance survey in Emam Reza hospital in Tabriz. J Infect Dis Trop Med 2012; 17: 7-12.
35. Asadollahi P, Akbari M, Soroush S, et al. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns 2012; 38(8): 1198-203. [http://dx.doi.org/10.1016/j.burns.2012.04.008] [PMID: 22579564]
36. Sohrabi N, Farajnia S, Akhi MT, et al. Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran. Microb Drug Resist 2012; 18(4): 385-9. [http://dx.doi.org/10.1089/mdr.2011.0077] [PMID: 22352411]
37. Aminzadeh Z, Yaghubi T. Drug-resistant post-neurosurgical nosocomial Acinetobacter baumannii meningitis in two Iranian hospitals. Afr J Biotechnol 2012; 11: 4083-4.
38. Vafaei S, Mirnejad R, Amirmozafari N, et al. Pattern of antibiotic resistance and the prevalence of antibiotic resistance in strains of betalactamases (ESBL) Acinetobacter baumannii isolated from clinical samples and phenotypic. J Infect Dis Trop Med 2012; 18: 39-44.
39. Talebi-Taher M, Latifnia M, Moosavi AJ, et al. Risk factors and antimicrobial susceptibility in ventilator associated pneumonia: a brief report. Tehran Univ Med J 2012; 70: 577-82.
40. Karbasizade V, Heidari L. Antimicrobial resistance of Acinetobacter baumannii isolated from Intensive Care Units of Isfahan hospitals, Iran. J Isfa Med Sch 2012; 30: 759.
41. Japoni S, Farshad S, Abdi Ali A, Japoni A. Antibacterial susceptibility patterns and cross-resistance of Acinetobacter, isolated from hospitalized patients, southern iran. Iran Red Crescent Med J 2011; 13(11): 832-6. [PMID: 22737424]
42. Mirnejad R, Mostofi S, Masjedian F. The role of class 2 integrons in antibiotic sensitivity strains Acinetobacter baumannii isolates from hospitals in Tehran. J Hamed Med Sch 2011; 18: 22-8.
43. Asadollahi K, Alizadeh E, Akbari M, et al. The role of bla(OXA-like carbapenemase) and their insertion sequences (ISS) in the induction of resistance against carbapenem antibiotics among Acinetobacter baumannii isolates in Tehran hospitals. Roum Arch Microbiol Immunol 2011; 70(4): 153-8. [PMID: 22568262]
44. Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol 2011; 3(2): 68-74. [PMID: 22347585]
45. Jazani NH, Babazadeh H, Sohrabpour M, et al. The prevalence of extended spectrum beta-lactamases in Acinetobacter baumannii isolates from burn wounds in Iran. Int J Microbiol 2011; 9: 1-3.
46. Asadollahi K, Taherikalani M, Maleki A, et al. Diversity of aminoglycoside modifying enzyme genes among multidrug resistant Acinetobacter baumannii genotypes isolated from nosocomial infections in Tehran hospitals and their association with class 1 integrons. Acta Microbiol Immunol Hung 2011; 58(4): 359-70. [http://dx.doi.org/10.1556/AMicr.58.2011.4.11][PMID: 22207293]
47. Vahdani P, Yaghoubi T, Aminzadeh Z. Hospital acquired antibiotic-resistant Acinetobacter baumannii infections in a 400-bed hospital in Tehran, Iran. Int J Prev Med 2011; 2(3): 127-30. [PMID: 21811653]
48. Peymani A, Nahaei MR, Farajnia S, et al. High prevalence of metallo-beta-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Jpn J Infect Dis 2011; 64(1): 69-71. [PMID: 21266761]
49. Mohammadtaheri Z, Pourpaki M, Mohammadi F, Namdar R, Masjedi MR. Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009. Chemotherapy 2010; 56(6): 478-84. [http://dx.doi.org/10.1159/000321032] [PMID: 21099220]
50. Akbari M, Niakan M, Taherikalani M, et al. Rapid identification of Iranian Acinetobacter baumannii strains by single PCR assay using BLA oxa-51 -like carbapenemase and evaluation of the antimicrobial resistance profiles of the isolates. Acta Microbiol Immunol Hung 2010; 57(2): 87-94. [http://dx.doi.org/10.1556/AMicr.57.2010.2.2] [PMID: 20587382]
51. Moradi-Tabriz H, Abdollahi A, Mehdipour B, et al. A baumannii, Infection rate and antimicrobial susceptibility in an Iranian tertiary care hospital. Iran J Pathol 2010; 5: 194-8.
52. Rahbar M, Mehrgan H, Aliakbari NH. Prevalence of antibiotic-resistant Acinetobacter baumannii in a 1000-bed tertiary care hospital in Tehran, Iran. Indian J Pathol Microbiol 2010; 53(2): 290-3. [http://dx.doi.org/10.4103/0377-4929.64333] [PMID: 20551535]
53. Jazani NH, Zartoshti M, Babazadeh H, et al. Antibacterial effects of Artemisia dracunculus essential oil on multi-dryg resistant isolates of Acinetobacter baumannii. Bacteriol J 2010; 1: 31-6. [http://dx.doi.org/10.3923/bj.2011.31.36]
54. Rahbar M, Mehragan H, Aliakbari NH. Prevalence of drug resistance in nonfermenter gram-negative bacilli. Iran J Pathol 2010; 5: 90-6.
55. Soroush S, Haghi-Ashtiani MT, Taheri-Kalani M, et al. Antimicrobial resistance of nosocomial strain of Acinetobacter baumannii in Children’s Medical Center of Tehran: a 6-year prospective study. Acta Med Iran 2010; 48(3): 178-84. [PMID: 21137655]
56. Taherikalani M, Fatolahzadeh B, Emaneini M, Soroush S, Feizabadi MM. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. New Microbiol 2009; 32(3): 265-71. [PMID: 19845108]
57. Jazani NH, Zartoshti M, Babazadeh H, Ali-daiee N, Zarrin S, Hosseini S. Antibacterial effects of Iranian fennel essential oil on isolates of Acinetobacter baumannii. Pak J Biol Sci 2009; 12(9): 738-41. [http://dx.doi.org/10.3923/pjbs.2009.738.741] [PMID: 19634482]
58. Shahcheraghi F, Akbari-Shahmirzadi N, Abbasalipour-Bashash M, et al. Molecular diagnosis of beta-lactamase genes blaTEM and blaCTX in Acinetobacter baumannii isolates in clinical samples at selected hospitals in Tehran. Iran. J Microbiol 2009; 3: 1-9.
59. Boroumand MA, Akhyani H, Sheikhvatan M, et al. Evaluation of antimicrobial resistance of Acinetobacter baumannii to Imipenem, Ciporofloxacin and Ceftazidime using E Test. Iran J Public Health 2009; 38: 130-3.
60. Hosseini-Jazani N, Babazadeh H, Khalkhali HR. An assessment of the sensitivity of Acinetobacter spp Burn isolates to Ciprofloxacin and some other antibiotics used for treatment. J Jah Univ Med Sci 2009; 7: 48-58.
61. Feizabadi MM, Fathollahzadeh B, Taherikalani M, et al. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn J Infect Dis 2008; 61(4): 274-8. [PMID: 18653968]
62. Khalatabadi-Farahani R, Moniri R, Shajari GH, et al. The pattern of spread of antibiotic resistance and antibiotic resistance genes in Acinetobacter spp isolates from Shahi Beheshti hospital, Kashan. J Feyz 2008; 12: 60-6.
63. Rahbar M, Kabeh-Monnavar M, Khadem-Vatan K, et al. Carbapenem resistance in gram-negative bacilli isolates in an Iranian 1000-bed tertiary hospital. Pak J Med Sci 2008; 24: 537-40.
64. Khosroshahi N, Sharifi M. Isolation of Carbapenem resistant Acinetobacter baumannii strains from patients in intensive care units of hospitals and facilities in Qazv in 2005-2006. Iran J Microbiol 2007; 1: 33-8.
65. Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 2010; 23(4): 332-9. [http://dx.doi.org/10.1097/QCO.0b013e32833ae38b] [PMID: 20581674]
66. Dinc G, Demiraslan H, Elmali F, et al. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis. Chemotherapy 2013; 59(5): 325-9. [http://dx.doi.org/10.1159/000356755] [PMID: 24525528]
67. Wang Y, Bao W, Guo N, et al. Antimicrobial activity of the imipenem/rifampicin combination against clinical isolates of Acinetobacter baumannii grown in planktonic and biofilm cultures. World J Microbiol Biotechnol 2014; 30(12): 3015-25. [http://dx.doi.org/10.1007/s11274-014-1728-7] [PMID: 25298216]
68. Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis 2010; 51(1): 79-84. [http://dx.doi.org/10.1086/653120] [PMID: 20504234]
69. Al-Agamy MH, Shibl AM, Ali MS, et al. Distribution of β-lactamases in carbapenem-non-susceptible Acinetobacter baumannii in Riyadh, Saudi Arabia. J Glob Antimicrob Resist 2013; 2: 17-21. [http://dx.doi.org/10.1016/j.jgar.2013.08.004]
70. Al-Sweih NA, Al-Hubail M, Rotimi VO. Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait. J Infect Public Health 2012; 5(1): 102-8. [http://dx.doi.org/10.1016/j.jiph.2011.11.004] [PMID: 22341849]
71. Begum S, Hasan F, Hussain S, Ali Shah A. Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from Tertiary Care Hospital in Islamabad, Pakistan. Pak J Med Sci 2013; 29(5): 1253-8. [PMID: 24353731]
72. Güven T, Yilmaz G, Güner HR, Kaya Kalem A, Eser F, Taşyaran MA. Increasing resistance of nosocomial Acinetobacter baumannii: are we going to be defeated? Turk J Med Sci 2014; 44(1): 73-8. [http://dx.doi.org/10.3906/sag-1211-21] [PMID: 25558562]
73. Sonnevend A, Ghazawi A, Al Munthari N, et al. Characteristics of epidemic and sporadic strains of Acinetobacter baumannii isolated in Abu Dhabi hospitals. J Med Microbiol 2013; 62(Pt 4): 582-90. [http://dx.doi.org/10.1099/jmm.0.055681-0] [PMID: 23264451]
74. Al-Agamy MH, Shibl AM, Ali MS, et al. Distribution of β-lactamases in carbapenem-non-susceptible Acinetobacter baumannii in Riyadh, Saudi Arabia. J Glob Antimicrob Resist 2013; 2: 17-21. [http://dx.doi.org/10.1016/j.jgar.2013.08.004]
75. Manchanda V, Sanchaita S, Singh N. Multidrug resistant Acinetobacter. J Glob Infect Dis 2010; 2(3): 291-304. [http://dx.doi.org/10.4103/0974-777X.68538] [PMID: 20927292]
76. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51(10): 3471-84. [http://dx.doi.org/10.1128/AAC.01464-06] [PMID: 17646423]
77. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46(8): 1254-63. [http://dx.doi.org/10.1086/529198] [PMID: 18444865]
78. Ronat JB, Kakol J, Khoury MN, et al. Highly drug-resistant pathogens implicated in burn-associated bacteremia in an Iraqi burn care unit. PLoS One 2014; 9(8): e101017. [http://dx.doi.org/doi:101371/journalpone0101017.]